This variant affects a residue far from the serine protease catalytic triad and was previously found to be significantly associated with TMPRSS2 rearrangements linked to the risk of prostate cancer [56] and a relatively shorter time to diagnosis for high-risk patients [57]. Here, TMPRSS2 is linked to Familial prostate cancer.